CINECA IRIS Institutional Research Information System

FOGLI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.293
AS - Asia 4.917
EU - Europa 4.831
SA - Sud America 693
Continente sconosciuto - Info sul continente non disponibili 416
AF - Africa 242
OC - Oceania 36
Totale 23.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.924
SG - Singapore 1.659
IT - Italia 1.572
CN - Cina 1.355
DE - Germania 727
SE - Svezia 677
HK - Hong Kong 676
BR - Brasile 561
VN - Vietnam 383
GB - Regno Unito 371
BG - Bulgaria 288
CA - Canada 255
FR - Francia 226
TR - Turchia 198
FI - Finlandia 183
IN - India 176
RU - Federazione Russa 165
AT - Austria 133
JP - Giappone 113
CI - Costa d'Avorio 82
PL - Polonia 81
UA - Ucraina 78
MX - Messico 58
BD - Bangladesh 54
NL - Olanda 52
KR - Corea 51
GR - Grecia 50
CH - Svizzera 49
ES - Italia 45
AR - Argentina 43
BE - Belgio 40
SN - Senegal 37
AU - Australia 33
PK - Pakistan 31
ZA - Sudafrica 30
IQ - Iraq 28
IL - Israele 26
ID - Indonesia 24
MA - Marocco 24
IR - Iran 22
VE - Venezuela 22
CO - Colombia 21
NG - Nigeria 20
RO - Romania 20
SA - Arabia Saudita 19
EC - Ecuador 18
PT - Portogallo 12
CR - Costa Rica 11
EG - Egitto 11
RS - Serbia 11
PH - Filippine 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
JO - Giordania 9
KE - Kenya 9
MY - Malesia 9
TW - Taiwan 9
NP - Nepal 8
UY - Uruguay 8
AL - Albania 6
CL - Cile 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
LT - Lituania 6
PE - Perù 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LB - Libano 5
PY - Paraguay 5
SV - El Salvador 5
TN - Tunisia 5
BY - Bielorussia 4
IE - Irlanda 4
KZ - Kazakistan 4
PA - Panama 4
AO - Angola 3
BJ - Benin 3
BO - Bolivia 3
CY - Cipro 3
DK - Danimarca 3
DM - Dominica 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
DZ - Algeria 2
GD - Grenada 2
GH - Ghana 2
KW - Kuwait 2
LY - Libia 2
Totale 22.985
Salva come PNG Salva come JPEG
Città #
Ashburn 1.239
Woodbridge 1.048
Singapore 852
Fairfield 702
Hong Kong 660
Santa Clara 653
Chandler 605
Ann Arbor 604
San Jose 593
Houston 569
Dallas 546
Serra 307
Shanghai 300
Sofia 284
Seattle 282
Beijing 268
Wilmington 266
New York 246
Milan 238
Cambridge 214
Council Bluffs 214
Los Angeles 189
Boardman 160
Ottawa 159
Princeton 144
Pisa 133
Lawrence 119
Vienna 118
London 109
Medford 106
Izmir 105
Lauterbourg 101
Ho Chi Minh City 97
Jacksonville 95
Tokyo 94
Florence 90
Nanjing 86
Munich 84
Abidjan 82
Hefei 81
Rome 79
Frankfurt am Main 78
Warsaw 68
Dearborn 67
Hanoi 65
Des Moines 61
Buffalo 59
São Paulo 59
Dong Ket 54
Redwood City 54
Redondo Beach 53
Helsinki 49
Istanbul 47
Ogden 45
Seoul 44
Lancaster 40
Dakar 37
Phoenix 37
Turku 36
Marseille 35
San Diego 35
Nanchang 34
Bern 33
San Francisco 33
Chicago 31
Columbus 31
Brooklyn 30
Orem 30
The Dalles 29
Brussels 27
Atlanta 26
Falls Church 26
Toronto 26
Jüchen 25
Montreal 24
Pune 24
Chennai 23
Bremen 22
Kunming 22
Tianjin 22
Fuzhou 21
Changsha 20
Guangzhou 20
Lagos 20
Nürnberg 20
Belo Horizonte 18
Naples 18
Rio de Janeiro 18
Mumbai 17
Brasília 15
Cascina 15
Denver 15
Johannesburg 15
Norwalk 15
Shenyang 15
Stockholm 15
Venice 15
Baltimore 14
Lucca 14
Memphis 14
Totale 14.796
Salva come PNG Salva come JPEG
Nome #
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 660
Sucrosomial® iron absorption studied by in vitro and ex-vivo models 521
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 379
The molecular bases of cannabinoid action in cancer 360
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells 347
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 306
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 293
Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis 269
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 265
Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules 252
Sucrosomial iron and traditional iron dosage forms are compared for absorption by Caco2 cells. 249
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 246
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism 243
A flexible SNP genotyping system to study allelic determinants of brain function. 240
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 239
Survivin-directed molecular beacon as potential theranostic agent in melanoma cells 236
Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells 233
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 231
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 227
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 226
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 223
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli. 219
Rosiglitazone reverses salbutamol-induced ß(2) -adrenoceptor tolerance in airway smooth muscle. 212
Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 212
Survivin mRNA detection and silencing by a Molecular Beacon Oligodeoxynucleotide in living cutaneous melanoma cells 211
Detection and silencing of survivin mRNA by bi-color imaging based on PMMA nanoparticles/molecular beacon in human cancer cells 209
Anticancer activity of anandamide in human cutaneous melanoma cells 208
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 204
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 204
Chronic administration of suramin induces neurotoxicity in rats 201
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. 199
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 197
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 195
Survivin directed molecular beacon as potential “theranostic agent” in melanoma cells 195
Evaluation of circulating microRNAs as diagnostic circulating biomarkers in cutaneous melanoma 195
Potential relationship between the expression of Cx26/Cx43 and the BRAF mutation status in human melanoma cells 195
Antiproliferative effects of Echinacea root hexanic extracts on Mia Paca-2 cells 192
Identification of five circulating microRNAs with high diagnostic values in cutaneous melanoma 191
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 190
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. 190
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 189
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 189
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. 188
Cannabinoid derivatives induce cell death in MIA Paca-2 cell line via a receptor-indipendent mechanism 187
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 187
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 185
Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines 184
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 183
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives 182
Clinical pharmacology of intravitreal anti-VEGF drugs 181
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 180
Theranostic properties of a survivin-directed molecular beacon in human melanoma cells 178
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 174
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 171
Montelukast reverses albuterol-induced b2-adrenoceptor tolerance in airway smooth muscle 170
Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells 170
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 170
A flexible SNP genotyping system to study allelic determinants of brain function 169
Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles 167
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 167
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 166
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 164
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 164
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer 163
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 163
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs 162
Pathophysiology and pharmacological targets of VEGF in diabetic macular edema 162
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 162
In vitro investigation of sulindac derivatives as potential anticancer agents 159
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 158
Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents. 155
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer 155
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 153
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 153
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 151
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 149
In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: Implications for asthma 148
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 146
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells 145
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 144
Influence of polysaccharides on expression of membrane-associated muc1 in cultivated epithelial cells 143
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 143
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 142
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 141
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 141
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 139
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 138
Farmacogenetica nelle neoplasie gastriche 137
New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration 137
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens 135
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 134
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 134
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 132
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage 131
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 131
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 128
Nicotine Metabolite Ratio in Smokers: A Real World Experience 128
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 127
Cross-Linked Hyaluronic Acid as Tear Film Substitute 126
ErbB in NSCLC as a molecular target: Current evidences and future directions 126
Totale 19.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.359 0 0 65 90 233 212 60 70 63 49 86 431
2022/20232.062 257 292 162 169 194 278 37 152 371 10 126 14
2023/20241.411 142 163 158 83 176 252 71 52 29 51 107 127
2024/20254.463 49 173 47 245 506 530 294 200 479 525 456 959
2025/20264.974 342 514 550 465 586 393 787 227 283 405 208 214
2026/20271.923 386 737 800 0 0 0 0 0 0 0 0 0
Totale 23.428